Three times weekly glatiramer acetate in relapsing–remitting multiple sclerosis
Year: 2013
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Annals of Neurology
DOI: 10.1002/ana.23938
Authors: Omar Khan, Peter Rieckmann, Alexey Boyko, Krzysztof Selmaj, Robert Zivadinov, GALA Study Group
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Teva Pharmaceutical Industries
OpenAlex ID: W1580917658
